|
EP3810127A1
|
|
Use of milbemycin oxime against sea lice on fish
|
|
EP3693465A1
|
|
Novel fish coronavirus
|
|
EP3693457A1
|
|
Novel fish totivirus
|
|
SG11202001085QA
|
|
Live fish processing system, and associated methods
|
|
US2019167772A1
|
|
Sea Lice Vaccine
|
|
GB201701573D0
|
|
Virus-like particle
|
|
GB201611512D0
|
|
Fish virus
|
|
GB201513872D0
|
|
Agent for use in treating fish parasites
|
|
GB201509004D0
|
|
Attenuated bacterium
|
|
GB201421962D0
|
|
Filtration method
|
|
GB201416633D0
|
|
Formulation
|
|
GB201416536D0
|
|
Formulation
|
|
CA2922621A1
|
|
Method for propagating a virus
|
|
CN111840531A
|
|
Immunogenic compositions against Aeromonas hydrophila
|
|
WO2012066481A1
|
|
New ethiological agent
|
|
WO2012001668A1
|
|
Anti-sea lice compositions and their use
|
|
CA2796178A1
|
|
Nucleic acid sequences of fish cardiomyopathy syndrome virus and the use thereof
|
|
CA3090088A1
|
|
Polyvalent vaccine against salmonid alphavirus infections
|
|
WO2009063044A1
|
|
Treatment of parasite diseases using vitamin k3
|
|
CA2634144A1
|
|
Novel fish pathogen
|
